Related Experiment Video
Updated: Sep 6, 2025
Treatment of Osteochondral Defects in the Rabbit's Knee Joint by Implantation of Allogeneic Mesenchymal Stem Cells in Fibrin Clots
Published on: May 21, 2013
Mesenchymal Stem Cell Mechanisms of Action and Clinical Effects in Osteoarthritis: A Narrative Review
Vilim Molnar1,2, Eduard Pavelić1, Kristijan Vrdoljak3
1St. Catherine Specialty Hospital, 10000 Zagreb, Croatia.
Abstract:
With the insufficient satisfaction rates and high cost of operative treatment for osteoarthritis (OA), alternatives have been sought. Furthermore, the inability of current medications to arrest disease progression has led to rapidly growing clinical research relating to mesenchymal stem cells (MSCs). The availability and function of MSCs vary according to tissue source. The three primary sources include the placenta, bone marrow, and adipose tissue, all of which offer excellent safety profiles. The primary mechanisms of action are trophic and immunomodulatory effects, which prevent the further degradation of joints. However, the function and degree to which benefits are observed vary significantly based on the exosomes secreted by MSCs. Paracrine and autocrine mechanisms prevent cell apoptosis and tissue fibrosis, initiate angiogenesis, and stimulate mitosis via growth factors. MSCs have even been shown to exhibit antimicrobial effects. Clinical results incorporating clinical scores and objective radiological imaging have been promising, but a lack of standardization in isolating MSCs prevents their incorporation in current guidelines.
Insights
Mesenchymal stem cells (MSCs) show promise for osteoarthritis treatment by reducing joint degradation. However, standardizing MSC isolation is crucial for widespread clinical adoption.
Area of Science:
- Regenerative Medicine
- Cell Biology
- Orthopedics
Background:
- Osteoarthritis (OA) treatment options have limitations, including low satisfaction rates and high costs.
- Current medications cannot halt OA progression, driving research into alternative therapies.
- Mesenchymal stem cells (MSCs) are a focus of clinical research for OA due to their therapeutic potential.
Purpose of the Study:
- To review the therapeutic potential of mesenchymal stem cells (MSCs) for osteoarthritis (OA).
- To explore the mechanisms of action and tissue sources of MSCs in OA treatment.
- To assess the clinical outcomes and challenges associated with MSC-based OA therapies.
Main Methods:
- Review of current clinical research on mesenchymal stem cells (MSCs) for osteoarthritis (OA).
- Analysis of MSC sources (placenta, bone marrow, adipose tissue) and their safety profiles.
- Examination of MSC mechanisms of action, including trophic, immunomodulatory, and exosome-mediated effects.
Main Results:
- MSCs demonstrate promising therapeutic effects through trophic and immunomodulatory actions, preventing joint degradation.
- Exosomes secreted by MSCs play a key role in paracrine and autocrine signaling, promoting tissue repair and inhibiting fibrosis.
- Clinical studies show promising results using clinical scores and radiological imaging, but standardization is lacking.
Conclusions:
- Mesenchymal stem cells (MSCs) offer a potential alternative for osteoarthritis (OA) treatment with promising safety profiles and therapeutic mechanisms.
- The efficacy of MSCs is influenced by their source and secreted exosomes, impacting their regenerative capabilities.
- Lack of standardization in MSC isolation protocols hinders their integration into current clinical guidelines for OA management.
More Related Videos
10:20Magnetic-Activated Cell Sorting Strategies to Isolate and Purify Synovial Fluid-Derived Mesenchymal Stem Cells from a Rabbit Model
Published on: August 10, 2018
09:48Large-Scale Preparation of Synovial Fluid Mesenchymal Stem Cell-Derived Exosomes by 3D Bioreactor Culture
Published on: July 26, 2022
Related Concept Videos
01:19Mesenchymal Stem Cells
01:21Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...